7Baggers
Quarterly
Annual
    Unit: USD2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2014-09-30 2013-12-31 2013-09-30 2013-03-31 2012-12-31 2012-09-30 2011-09-30 2010-12-31 2010-09-30 2010-03-31 2009-12-31 2009-09-30 2008-09-30 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-03-31 2004-12-31 2004-09-30 2004-03-31 2003-12-31 2003-09-30 2003-03-31 2002-12-31 2002-09-30 2002-03-31 2001-12-31 2001-09-30 
      
    		                                                                 
      revenues:
    		                                                                 
      product revenue
    		105,164,000 77,371,000 29,544,000                                                               
      license and milestone fees
    		   30,780,000 7,382,000 6,973,000 30,892,000 19,564,000 2,677,000 252,000 157,000 62,417,000 97,000 945,000 283,000 29,551,000 79,000 5,079,000 79,000 1,747,000 672,000 1,321,000 11,540,000 60,739,000 18,730,000 76,000 76,000 10,077,000 10,692,000 6,070,000 6,234,000 25,678,000 13,167,000 22,010,000 429,000 933,000 1,187,000 866,000 1,810,000 1,266,000 827,000 1,831,000 2,223,000 2,680,000 4,188,000 -6,323,415 1,497,000 3,428,000 1,406,000 1,340,000 3,275,000 1,275,000 1,261,000 3,039,394            
      non-cash royalty revenue related to the sale of future royalties
    		       8,040,000 6,533,000 16,690,000         8,488,000 9,281,000 8,441,000 7,242,000 7,190,000 20,529,000 7,613,000 6,184,000 5,944,000 7,380,000 6,291,000 5,684,000                                    
      research and development support
    		855,000  455,000 109,000  73,000 758,000 388,000  6,000 4,000 11,000 5,000 5,000 7,000   51,000 17,000 218,000 388,000 388,000 383,000 2,004,000 1,478,000 1,354,000 1,335,000 1,059,000 848,000 772,000 776,000 1,922,000 1,990,000 2,257,000 2,036,000 1,377,000 1,068,000 2,005,000 1,495,000 1,805,000 1,283,000 782,000 3,207,000 3,672,000 4,473,000 -18,657,514 6,583,000 6,593,000 5,507,000 5,674,000 5,258,000 5,231,000 5,645,000 4,572,792 4,065,955 4,089,008 4,059,524 3,886,386 1,207,681       
      total revenues
    		113,425,000 83,153,000 49,869,000 41,167,000 15,375,000 14,162,000 38,078,000 27,992,000 9,210,000 16,948,000 15,706,000 85,798,000 18,189,000 15,025,000 13,287,000 44,864,000 13,281,000 15,542,000 8,584,000 13,416,000 10,928,000 9,287,000 19,815,000 86,948,000 28,499,000 7,660,000 7,408,000 19,714,000 18,029,000 14,851,000 13,203,000 30,060,000 17,218,000 25,001,000 2,612,000 4,091,000 2,536,000 4,178,000 3,411,000 3,314,000 3,108,000 3,099,000 6,126,000 9,751,000 11,425,000 -29,639,788 9,836,000 12,072,000 7,770,000 8,368,000 9,355,000 6,587,000 7,778,000 10,230,493 9,047,218 9,006,526 7,589,612 5,163,720 3,890,183 1,456,470 2,476,159 2,346,310 1,210,334 1,544,413 1,425,901 
      cost and operating expenses:
    		                                                                 
      cost of sales
    		                                                                 
      research and development
    		47,570,000 50,077,000 51,620,000 58,485,000 59,181,000 51,422,000 44,282,000 48,968,000 33,147,000 34,589,000 34,413,000 39,578,000 24,685,000 22,921,000 27,408,000 26,055,000 21,015,000 28,559,000 38,893,000 43,681,000 47,243,000 38,701,000 44,831,000 106,851,000 32,888,000 32,909,000 38,652,000 36,094,000 38,199,000 35,132,000 28,018,000 20,862,000 22,029,000 21,318,000 21,656,000 23,700,000 17,161,000 16,004,000 13,425,000 12,091,000 12,211,000 12,188,000 11,860,000 10,732,000 9,105,000 -11,464,163 3,991,000 3,846,000 11,416,000 12,441,000 10,216,000 8,760,000 9,492,000 9,819,540 6,616,745 7,855,096 6,169,830 5,194,770 4,771,367 6,295,903 6,566,748 4,109,351 7,173,051 3,015,212 2,503,556 
      selling, general and administrative
    		37,744,000 36,356,000 40,016,000 42,065,000 33,623,000 23,793,000 16,648,000                                                           
      total cost and operating expenses
    		87,469,000 87,342,000 92,262,000                                                               
      income from operations
    		25,956,000 -4,189,000 -42,393,000 -59,559,000 -77,429,000 -61,053,000 -22,852,000 -34,554,000 -34,234,000 -27,369,000 -28,916,000 36,519,000 -16,727,000 -18,362,000 -23,810,000 8,494,000 -17,962,000 -41,059,000 -41,646,000 -40,423,000 -45,532,000 -38,752,000 -36,742,000 -46,088,000 -12,894,000 -38,838,000      3,751,000                 -7,089,000 -7,542,000 -3,833,000 -4,599,000 -5,412,000             
      yoy
    		-133.52% -93.14% 85.51% 72.36% 126.18% 123.07% -20.97% -194.62% 104.66% 49.05% 21.44% 329.94% -6.88% -55.28% -42.83% -121.01% -60.55% 5.95% 13.35% -12.29% 253.13% -0.22%                           30.99%                 
      qoq
    		-719.62% -90.12% -28.82% -23.08% 26.82% 167.17% -33.87% 0.93% 25.08% -5.35% -179.18% -318.32% -8.90% -22.88% -380.32% -147.29% -56.25% -1.41% 3.03% -11.22% 17.50% 5.47% -20.28% 257.44% -66.80%                        -6.01% 96.76% -16.66% -15.02%              
      operating margin %
    		                                                                 
      interest income
    		7,383,000 5,223,000                                            624,250 757,000 874,000 865,000 923,000 875,000 758,000 718,000 544,655 457,176 363,947 321,739 353,305 379,372 592,466 740,814 892,407 1,084,386 1,295,868 1,644,937 
      interest expense on term loan
    		                                                                 
      non-cash interest expense on liability related to the sale of future royalties and term loan
    		                                                                 
      other income
    		-164,000 -8,000 63,000 582,000 -998,000 -480,000 -98,000 -483,000 -365,000 197,000 -480,000 562,000 11,000 106,000 -198,000 1,015,000 -521,000 167,000 -71,000 -305,000 -75,000 -1,052,000 537,000 1,327,000 134,000 129,000 -530,000 551,000    62,000 111,000  115,000 56,000  1,281,000 490,000   144,000 16,000 727,000 813,000  69,000  -18,000 -31,000 -15,000 366,000  447  7,034 890 30,000 593 1,409,665  12,692 1,332 3,307 26,670 
      net income before income taxes
    		                                                                 
      income tax benefit
    		                                                                 
      net income
    		30,748,000  -41,014,000 -40,980,250 -77,755,000 -62,021,000 -24,145,000 -37,172,000 -37,339,000 -30,741,000 -34,051,000 31,388,000 -22,374,000 -24,298,000 -29,088,000 4,814,000 -21,750,000 -43,446,000 -43,751,000 -41,799,000 -46,807,000 -41,624,000 -38,613,000 -78,667,000 -17,345,000 -44,731,000 -45,922,000 -31,928,000 -33,227,000 -33,740,000 -22,282,000 3,813,000 -11,226,000 -1,351,000 -24,393,000 -25,192,000 -19,483,000 -14,233,000 -12,888,000 -12,124,000 -13,008,000 -12,375,000 -9,397,000 -6,212,000 -1,032,000 14,439,013 -5,161,000 -3,044,000 -6,253,000 -6,645,000 -2,981,000 -3,502,000 -4,706,000 -3,550,976 -2,209,378 -2,470,506 -759,921 -1,332,609 -4,126,414 -4,616,581 -5,285,198 -3,221,537 -6,872,868 -1,732,252 -1,592,523 
      yoy
    		-139.54%  69.87% 10.24% 108.24% 101.75% -29.09% -218.43% 66.89% 26.52% 17.06% 552.01% 2.87% -44.07% -33.51% -111.52% -53.53% 4.38% 13.31% -46.87% 169.86% -6.95% -15.92% 146.39% -47.80% 32.58% 106.09% -937.35% 195.98% 2397.41% -8.65% -115.14% -42.38% -90.51% 89.27% 107.79% 49.78% 15.01% 37.15% 95.17% 1160.47% -185.71% 82.08% 104.07% -83.50% -317.29% 73.13% -13.08% 32.87% 87.13% 34.92% 41.75% 519.27% 166.47% -46.46% -46.49% -85.62% -58.63% -39.96% 166.51% 231.88%     
      qoq
    		  0.08% -47.30% 25.37% 156.87% -35.05% -0.45% 21.46% -9.72% -208.48% -240.29% -7.92% -16.47% -704.24% -122.13% -49.94% -0.70% 4.67% -10.70% 12.45% 7.80% -50.92% 353.54% -61.22% -2.59% 43.83% -3.91% -1.52% 51.42% -684.37% -133.97% 730.94% -94.46% -3.17% 29.30% 36.89% 10.44% 6.30% -6.80% 5.12% 31.69% 51.27% 501.94% -107.15% -379.77% 69.55% -51.32% -5.90% 122.91% -14.88% -25.58% 32.53% 60.72% -10.57% 225.10% -42.97% -67.71% -10.62% -12.65% 64.06% -53.13% 296.76% 8.77%  
      net income margin %
    		                                                                 
      net income per common share - basic
    		100                                                                 
      net income per common share - diluted
    		100                                                                 
      weighted-average common shares outstanding - basic
    		                                                                 
      weighted-average common shares outstanding - diluted
    		                                                                 
      income tax expense
    		                                             7,000 9,000 9,000 10,000  1,000 6,000 10,000 4,949 19,628 2,872 4,207 10,290 10,290  12,850 22,275 33,000 33,000 61,812 
      basic and diluted net income per common share
    		 -20 -160 -230 -310 -240 -100 -170 -180 -150 -170 190 -130 -140 -170 40 -150 -290 -300 -290 -320 -310 -300 -780 -200 -510 -530 -370 -380 -390 -260 40 -130 -20 -290 -300 -260 -210 -190 -210 -230 -220 -190 -150 -20 349.55 -120 -70 -150 -160 -70 -90 -110 -0.09 -0.05 -0.06 -0.02 -0.03 -0.1 -0.11 -0.12 -0.08    
      basic and diluted weighted-average common shares outstanding
    		 263,446,000 258,848,000 253,631,000 253,511,000 253,336,000 253,263,000 206,147,000 204,844,000 199,890,000 198,835,000 176,153,000 174,508,000 174,354,000 166,947,000 148,311,000 148,479,000 148,129,000 147,813,000 139,946,000 147,220,000 134,384,000 130,619,000 98,068,000 87,160,000 87,102,000 86,976,000 87,035,000  86,838,000 85,872,000  85,010,000 84,279,000 84,147,000 83,350,000 76,364,000 67,965,000 67,944,000 57,365,000 57,156,000 57,032,000 50,783,000 42,700,000 42,416,000 41,759 41,705,000 41,571,000 41,482,000 41,184,000 41,188,183,000 41,079,000 41,065,000 40,870,768 40,800,073 40,789,332 40,662,750 40,597,674 40,589,012 41,440,747 42,773,645 42,825,811    
      investment income
    		  2,169,000 2,158,000 1,539,000 590,000 54,000 16,000 11,000 11,000 13,000 10,000 11,000 62,000 646,000 683,000 1,032,000 1,287,000 1,422,000 1,382,000 1,369,000 814,000 662,000 1,031,000 115,000 146,000 106,000 108,000 60,000 51,000                                    
      non-cash interest expense on liability related to the sale of future royalties
    		                                                                 
      total comprehensive loss
    		  -41,014,000 -59,008,000 -77,755,000 -62,021,000 -24,145,000 -37,172,000 -37,339,000 -30,741,000 -34,051,000 31,388,000 -22,374,000 -24,298,000 -29,088,000 4,814,000 -21,750,000 -43,446,000 -43,751,000 -41,799,000 -46,807,000 -41,624,000 -38,613,000 -78,667,000 -17,345,000 -44,731,000 -45,922,000 -31,928,000  -33,740,000 -22,282,000  -11,226,000                                 
      operating expenses:
    		                                                                 
      total operating expenses
    		   57,237,250 92,804,000 75,215,000 60,930,000 62,546,000 43,444,000 44,317,000 44,622,000 49,279,000 34,916,000 33,387,000 37,097,000 36,370,000 31,243,000 56,601,000 50,230,000 53,839,000 56,460,000 48,039,000 56,557,000 133,036,000 41,393,000 46,498,000 47,950,000 47,329,000 46,253,000 43,461,000 35,113,000 26,309,000 28,555,000 26,313,000 27,120,000 29,339,000 22,002,000 19,692,000 16,789,000 15,538,000 16,097,000 15,780,000 15,538,000 16,685,000 13,258,000                     
      non-cash interest expense on liability related to the sale of future royalties and convertible senior notes
    		                  -3,432,000 -2,428,000 -2,546,000 -2,611,000 -3,046,000 -10,107,000 -3,575,000 -5,018,000                                        
      interest expense on convertible senior notes
    		                  -24,000 -25,000 -23,000 -23,000 -24,000 -1,915,000 -1,125,000 -1,150,000                                        
      general and administrative
    		       13,578,000 10,297,000 9,728,000 10,209,000 9,738,000 10,231,000 9,767,000 8,864,000 9,803,000 9,208,000 8,700,000 10,778,000 9,752,000 8,347,000 8,652,000 9,995,000 25,792,000 8,119,000 9,459,000 9,298,000 11,235,000 8,054,000 8,329,000 7,095,000 5,447,000 6,526,000 4,995,000 5,464,000 5,639,000 4,841,000 3,688,000 3,364,000 3,447,000 3,886,000 3,592,000 3,678,000 3,527,000 2,424,000 -8,199,971 2,848,000 2,566,000 2,797,000 2,579,000 2,193,000 2,332,000 2,794,000 2,161,167 2,033,973 1,493,002 1,768,550 1,412,206 1,834,223 1,502,253 1,296,974 1,742,374 1,576,469 1,242,262 1,198,575 
      restructuring charges
    		                                                                 
      restructuring charge
    		                  559,000 406,000 870,000 686,000 1,731,000 393,000 386,000 4,130,000                                        
      clinical materials revenue
    		                   2,170,000 1,427,000 336,000 702,000 3,676,000 678,000 46,000 53,000 1,198,000 3,000 2,325,000 2,027,000 125,000 8,000 734,000 147,000 1,781,000                              
      non-cash debt conversion expense
    		                                                                 
      royalty revenue
    		                            195,000  4,166,000 2,335,000 2,053,000                                 
      basic weighted-average common shares outstanding
    		                            86,970,000   85,431,000                                  
      dilutive impact of potential common shares
    		                               1,845,000                                  
      diluted weighted-average common shares outstanding
    		                            86,970,000   87,276,000                                  
      total comprehensive income
    		                            -33,227,000   3,813,000                                  
      comprehensive loss
    		                                 -1,351,000 -24,393,000 -25,192,000                              
      clinical materials reimbursement
    		                                    281,000 1,307,000 106,000 243,000 998,000 486,000 696,000 3,399,000 2,764,000 -4,658,859 1,756,000 2,051,000 857,000 1,354,000 822,000 81,000 831,000 2,415,158 3,637,099 2,865,583 936,405 226,827 1,948,700 492,458 947,896 826,269 601,777 840,855 934,561 
      income before benefit from income taxes
    		                                                                 
      benefit from income taxes
    		                                          1,000 5,000 12,000                     
      income before benefit for income taxes
    		                                                                 
      benefit for income taxes
    		                                                                 
      cost of clinical materials reimbursed
    		                                           2,426,000 1,729,000 -3,228,428 997,000 1,588,000 646,000 890,000 779,000 94,000 904,000 2,285,841 3,042,421 2,493,937 729,050 226,826 1,758,809 439,872 843,168 752,396 556,677 840,855 934,561 
      expenses:
    		                                                                 
      preclinical and clinical
    		                                             1,556,000 2,079,000 2,218,000                  
      process and product development
    		                                             1,017,250 1,391,000 1,367,000                  
      manufacturing
    		                                             3,336,500 4,504,000 4,337,000                  
      total expenses
    		                                             11,648,000 15,810,000 15,922,000 14,859,000 15,910,000 13,188,000 11,186,000 13,190,000 14,266,548 11,693,139 11,842,035 8,667,430 6,833,802 8,364,399 8,238,028 8,706,890 6,604,121 9,306,197 5,098,329 4,636,692 
      net realized losses on investments
    		                                                -1,000 -8,250 -7,000 -22,000              
      gain on sale of assets
    		                                             250 1,000 1,000    1,000 2,000             
      income before income tax expense
    		                                                -6,243,000 -6,645,000 -2,980,000 -3,496,000 -4,696,000             
      net realized gains on investments
    		                                               5,000                  
      development fees
    		                                                    41,000 203,149 310,325 509,763 43,179  87,476 178,306 48,578 40,370 148,616 314,742 94,723 
      license fees and milestone payments
    		                                                      1,033,839 1,542,172 2,550,504 1,050,507 646,326       
      revenue earned under collaboration agreements
    		                                                           785,706 1,479,685 1,479,671 459,941 388,816 396,617 
      realized gains on investments
    		                                                           162,846 217,569 153,450 170,277 555,289 8,473 
      net income before income tax expense
    		                                                                 
      gain/(loss) on sale of assets
    		                                                               200  
      income before income tax expense and cumulative effect of change in accounting principle
    		                                                                 
      income before cumulative effect of change in accounting principle
    		                                                              -0.17 -0.04 -0.04 
      cumulative effect of change in accounting principle
    		                                                                 
      basic and diluted net income per common share:
    		                                                                 
      basic and diluted average common shares outstanding
    		                                                              39,829,837 39,730,478 38,809,948 
      loss on the sale of assets
    		                                                                 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.